Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Developing Violence Prevention Therapy for Substance Abusers

This study has been completed.
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
Stephen Chermack, University of Michigan
ClinicalTrials.gov Identifier:
NCT00551863
First received: October 30, 2007
Last updated: August 4, 2015
Last verified: August 2015

October 30, 2007
August 4, 2015
June 2004
March 2008   (final data collection date for primary outcome measure)
Interpersonal Violence [ Time Frame: 3 and 6 month follow-up ] [ Designated as safety issue: No ]
Interpersonal Violence [ Time Frame: 3 and 6 month follow-up ]
Complete list of historical versions of study NCT00551863 on ClinicalTrials.gov Archive Site
alcohol and drug use [ Time Frame: 3 and 6 month follow-up ] [ Designated as safety issue: No ]
alcohol and drug use [ Time Frame: 3 and 6 month follow-up ]
Not Provided
Not Provided
 
Developing Violence Prevention Therapy for Substance Abusers
Development of Violence Therapy for Substance Abusers
The purpose of this project is to develop and pilot test a violence prevention intervention for men and women in treatment for substance use problems.
Not Provided
Interventional
Phase 1
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Substance Use Disorders
  • Violence
Behavioral: IVPT
Violence prevention intervention based on Motivational Interviewing and CBT
Active Comparator: IVPT
Intervention based on Motivational Interviewing and CBT
Intervention: Behavioral: IVPT

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
131
March 2008
March 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Presence of substance use related problems
  • Interpersonal Violence history in the year before recruitment

Exclusion Criteria:

  • Primary opiate dependence
  • Presence of active psychotic disorder
  • < 18 years of age
Both
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00551863
R01DA017295-01A1, R01DA017295
No
Not Provided
Not Provided
Stephen Chermack, University of Michigan
University of Michigan
National Institute on Drug Abuse (NIDA)
Principal Investigator: Stephen T Chermack, Ph.D. University of Michigan
University of Michigan
August 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP